Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...

While some warn of the danger of having someone suffering from ‘cognitive decline’ in the White House, his inner circle ...

In a recent study, researchers found that exercise and aggressive cardiovascular risk reduction successfully improved heart ...

What you need to know Falls are common in older people, and fall related injuries are a substantial cause of morbidity and ...

The MIND diet may help protect the aging brain against structural deterioration, such as grey matter loss, a new study has ...

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for ...

The field of Alzheimer’s disease (AD) research has evolved significantly, shifting from a sole reliance on clinical diagnosis to an integrated approach ...

In a study published in eNeuro, Lena Ting, from Emory University, and colleagues explored how brain and muscle activity ...

Get an up-close look at one a playground designed exclusively for seniors. Using low-impact equipment, seniors can move their ...

When it comes to balance, more effort from the brain and muscles may actually mean less control—and a higher risk of falling.